JoVE Logo

Anmelden

5.6 : Phase I Reactions: Hydrolytic Reactions

Hydrolysis, a cornerstone of phase I biotransformation reactions, uses water to cleave chemical bonds. This process is pivotal in drug metabolism, generating more polar metabolites that can be easily excreted.

An important hydrolytic reaction is ester hydrolysis. Ester bonds, often found in prodrugs, are broken down, increasing the solubility of drugs like aspirin and lidocaine for more straightforward elimination. Amide hydrolysis is another critical reaction, targeting amide bonds prevalent in numerous drugs. Secondary amides like acetaminophen and tertiary amides like lidocaine undergo hydrolysis, resulting in corresponding carboxylic acids and amines. Hydrazides like isoniazid also experience hydrolysis, yielding carboxylic acid and hydrazine.

Nonaromatic heterocycles, including imidazoles and pyrazoles, can also be hydrolyzed. For instance, metronidazole transforms into the respective carboxylic acid and alcohol through hydrolysis. Hydrolytic dehalogenation, removing a halogen atom from a molecule, represents another hydrolytic mechanism. Chloramphenicol, for example, can be hydrolyzed into its corresponding carboxylic acid and alcohol. Miscellaneous hydrolytic reactions extend to the hydrolysis of thioesters like captopril, which transforms into the respective carboxylic acid and thiol.

Hydrolysis significantly contributes to phase I biotransformation reactions in drug metabolism. The process enhances the polarity and solubility of metabolites, facilitating their excretion and playing an indispensable role in drug elimination.

Tags

Phase I ReactionsHydrolytic ReactionsHydrolysisDrug MetabolismEster HydrolysisAmide HydrolysisCarboxylic AcidsAcetaminophenLidocaineHydrazidesMetronidazoleHydrolytic DehalogenationChloramphenicolThioestersDrug Elimination

Aus Kapitel 5:

article

Now Playing

5.6 : Phase I Reactions: Hydrolytic Reactions

Pharmacokinetics: Drug Biotransformation

81 Ansichten

article

5.1 : Drug Biotransformation: Overview

Pharmacokinetics: Drug Biotransformation

402 Ansichten

article

5.2 : Phase I Oxidative Reactions: Overview

Pharmacokinetics: Drug Biotransformation

246 Ansichten

article

5.3 : Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Pharmacokinetics: Drug Biotransformation

151 Ansichten

article

5.4 : Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems

Pharmacokinetics: Drug Biotransformation

69 Ansichten

article

5.5 : Phase I Reactions: Reductive Reactions

Pharmacokinetics: Drug Biotransformation

184 Ansichten

article

5.7 : Phase II Conjugation Reactions: Overview

Pharmacokinetics: Drug Biotransformation

169 Ansichten

article

5.8 : Phase II Reactions: Glucuronidation

Pharmacokinetics: Drug Biotransformation

312 Ansichten

article

5.9 : Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

Pharmacokinetics: Drug Biotransformation

182 Ansichten

article

5.10 : Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Pharmacokinetics: Drug Biotransformation

157 Ansichten

article

5.11 : Phase II Reactions: Acetylation Reactions

Pharmacokinetics: Drug Biotransformation

193 Ansichten

article

5.12 : Phase II Reactions: Methylation Reactions

Pharmacokinetics: Drug Biotransformation

150 Ansichten

article

5.13 : Phase II Reactions: Miscellaneous Conjugation Reactions

Pharmacokinetics: Drug Biotransformation

48 Ansichten

article

5.14 : Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs

Pharmacokinetics: Drug Biotransformation

195 Ansichten

article

5.15 : Factors Affecting Drug Biotransformation: Biological

Pharmacokinetics: Drug Biotransformation

124 Ansichten

JoVE Logo

Datenschutz

Nutzungsbedingungen

Richtlinien

Forschung

Lehre

ÜBER JoVE

Copyright © 2025 MyJoVE Corporation. Alle Rechte vorbehalten